Status: Not yet recruiting
PACE-AF: Prospective Analysis of Cardiac Electrostimulation and Atrial Fibrillation
PACE-AF is a prospective, observational patient registry designed to evaluate the impact of pacemaker algorithms on atrial fibrillation (AF) incidence, progression, and clinical outcomes in patients implanted with dual-chamber pacemakers. The registry aims to include 400-500 patients with longitudinal follow-up. Primary outcomes are progression to permanent AF and all-cause mortality. Secondary outcomes include quality of life, hospitalization, and cardiovascular events.
Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ilya LukinUpdated: Dec 12, 2025Locations: 1Duration: 3 Years
Eligibility criteria
• Age ≥ 18 years [+3]
• Single-chamber pacemaker or Cardiac Resynchronization Therapy device at baseli... [+3]